SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study

SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study

BackgroundThe identification of high-risk population patients is key to the personalized treatment options for the stage II colorectal cancers. The use of proteomics in the prognosis of patients with stage II colorectal cancer remains unclear.MethodsUsing quantitative proteomics, we analyzed protein...

Full description

Bibliographic Details
Main Authors: Dingyun You, Shuai Zhang, Shan Yan, Yingying Ding, Chunxia Li, Xianshuo Cheng, Lin Wu, Weizhou Wang, Tao Zhang, Zhenhui Li, Yongwen He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
SAMHD1
colorectal cancer
Cox model
prognostic markers
nested case-control design
MSI
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.939982/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.939982/full

Similar Items